Chapter title |
Drug Delivery Devices for Inhaled Medicines
|
---|---|
Chapter number | 67 |
Book title |
Pharmacology and Therapeutics of Asthma and COPD
|
Published in |
Handbook of experimental pharmacology, January 2016
|
DOI | 10.1007/164_2016_67 |
Pubmed ID | |
Book ISBNs |
978-3-31-952173-2, 978-3-31-952175-6
|
Authors |
Anne Lexmond, Ben Forbes, Lexmond, Anne, Forbes, Ben |
Abstract |
Historically, the inhaled route has been used for the delivery of locally-acting drugs for the treatment of respiratory conditions, such as asthma, COPD, and airway infections. Targeted delivery of substances to the lungs has some key advantages over systemic administration, including a more rapid onset of action, an increased therapeutic effect, and, depending on the agent inhaled, reduced systemic side effects since the required local concentration in the lungs can be obtained with a lower dose. Fortunately, when designed properly, inhaled drug delivery devices can be very effective and safe for getting active agents directly to their site of action. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 4 | 12% |
Student > Bachelor | 3 | 9% |
Professor | 3 | 9% |
Researcher | 3 | 9% |
Student > Ph. D. Student | 2 | 6% |
Other | 4 | 12% |
Unknown | 15 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 18% |
Nursing and Health Professions | 5 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 12% |
Chemistry | 2 | 6% |
Immunology and Microbiology | 1 | 3% |
Other | 1 | 3% |
Unknown | 15 | 44% |